Jessica Thornton v. Commissioner of Social Security

CourtDistrict Court, N.D. Ohio
DecidedNovember 25, 2025
Docket1:25-cv-00712
StatusUnknown

This text of Jessica Thornton v. Commissioner of Social Security (Jessica Thornton v. Commissioner of Social Security) is published on Counsel Stack Legal Research, covering District Court, N.D. Ohio primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Jessica Thornton v. Commissioner of Social Security, (N.D. Ohio 2025).

Opinion

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF OHIO EASTERN DIVISION

JESSICA THORNTON, CASE NO. 1:25-CV-00713-JRA

Plaintiff, JUDGE JOHN R. ADAMS

vs. MAGISTRATE JUDGE DARRELL A. CLAY

COMMISSIONER OF SOCIAL SECURITY, REPORT AND RECOMMENDATION

Defendant.

INTRODUCTION Plaintiff Jessica Thornton challenges the Commissioner of Social Security’s decision denying disability insurance benefits (DIB). (ECF #1). The District Court has jurisdiction under 42 U.S.C. §§ 1383(c) and 405(g). This matter was referred to me under Local Civil Rule 72.2 to prepare a Report and Recommendation. (Non-document entry dated Apr. 9, 2025). For the reasons below, I recommend the District Court AFFIRM the Commissioner’s decision. PROCEDURAL BACKGROUND Ms. Thornton applied for DIB on February 26, 2021. (Tr. 139). She alleged she became disabled on December 31, 2015 due to rheumatoid arthritis, fibromyalgia, depression, anxiety, cystitis, gastroesophageal reflux disease, hernia, ankylosing spondylitis, endometriosis, bladder inflammation, chronic UTI, migraines, lymphadenopathy, gastritis, bone infection in her jaw, and dizzy spells. (Tr. 91). After the claims were denied initially and on reconsideration, Ms. Thornton requested a hearing before an administrative law judge. (Tr. 147, 158, 168). On September 19, 2022, Ms. Thornton (represented by counsel) and a vocational expert (VE) testified before the ALJ. (Tr. 63-90). On November 9, 2022, the ALJ determined Ms. Thornton was not disabled. (Tr. 113). On September 8, 2023, the Appeals Council remanded Ms. Thornton’s case to evaluate

the entire period of disability from the correct date last insured, re-evaluate her severe impairments, and re-evaluate her ability to perform her past relevant work. (Tr. 134-36). On January 24, 2023, Ms. Thornton (represented by counsel) and a different VE testified before a different ALJ. (Tr. 36-62). On February 23, 2024, the ALJ again determined Ms. Thornton was not disabled. (Tr. 17-30). On August 24, 2023, the Appeals Council denied Ms. Thornton’s request for review, making the hearing decision the final decision of the Commissioner. (Tr. 1-3; see also 20 C.F.R. § 404.981). On April 9, 2025, Ms. Thornton timely filed this action. (ECF #1).

FACTUAL BACKGROUND I. Personal and Vocational Evidence Ms. Thornton was 28 years old on her alleged onset date and 36 years old at the second hearing. (See Tr. 91). She has a date last insured of September 30, 2022. (See Tr. 135). She holds two associate’s degrees. (Tr. 71, 95). She has past relevant work experience as a food salesclerk and a weight-reduction specialist. (Tr. 59). At the time of the second hearing, she worked 20 hours a

week at a grocery store self-checkout line. (Tr. 43-44). II. Relevant Medical Evidence1 Ms. Thornton has a history of rheumatoid arthritis, chronic lower-back pain, and fibromyalgia. (See Tr. 825, 1001). In May 2021, she was worried her arthritis was returning as she

1 Although Ms. Thornton claimed disability in part due to mental impairments, her arguments here relate solely to the ALJ’s evaluation of her physical impairments, so I limit my discussion to those impairments. had lower-back and joint pain and inflammation in her hand. (Tr. 802). Her rheumatologist, Dr. Gheorghe Ignat, re-prescribed sulfasalazine that she previously took with success in 2017.2 (Tr. 801-02). By January 2022, she reported worsening headaches, neck pains, and dizziness. (Tr. 1040).

Dr. Ignat suspected her medication was inducing the headaches and prescribed an anti-headache medication. (Tr. 1039). A physical examination found mild synovitis (inflammation of the joint lining) in her hands and tenderness in her feet, but otherwise yielded normal findings. (Tr. 1042). In a follow-up visit the next week, Dr. Ignat noted Ms. Thornton’s rheumatoid factor was “very high” and assessed her with seropositive rheumatoid arthritis. (Tr. 1034). By March, Dr. Ignat slowly increased Ms. Thornton’s dose of anti-inflammatory medication. (Tr. 1027). In May 2022, Ms. Thornton was referred for an electromyograph of her legs; it revealed

“[c]hronic bilateral lumbosacral radiculopathy with recent worsening by a history of rheumatoid arthritis and fibromyalgia.” (Tr. 1003). In June 2022, x-ray imaging of Ms. Thornton’s lumbar spine yielded normal findings. (Tr. 1006). At the next follow-up visit in August 2022, Ms. Thornton was also observed with bronchitis, memory problems, gastrointestinal problems, numbness in her legs, and mild radiculopathy in her right L3-L4 vertebrate. (Tr. 1021). Ms. Thornton first underwent a colonoscopy in December 2016. (Tr. 955). It yielded

generally normal findings. (Tr. 956). In November 2020, she complained of esophageal reflux that persisted despite therapy and underwent an endoscopy. (Tr. 936). The doctor observed reflux esophagitis and a small hiatal hernia, but otherwise normal findings. (Tr. 937). She was prescribed

2 Sulfasalazine is an anti-inflammatory medication prescribed to treat ulcerative colitis and rheumatoid arthritis and it can cause headaches as a side-effect. See Sulfasalazine, MedlinePlus, http://medlineplus.gov/druginfo/meds/a682204.html (last accessed Nov. 18, 2025). Omeprazole and a diet to reduce reflux.3 (Id.). In July 2021, she presented to the emergency room with abdominal pain but the doctors could not ascertain the cause of her pain, so she was advised to follow up with her gastroenterologist. (Tr. 927, 931). She did so, where she underwent a

colonoscopy. (Tr. 914). By that time, it appears Ms. Thornton’s anti-reflux medication was switched from omeprazole to pantoprazole.4 (See Tr. 920). But the record also reports she “took herself off pantoprazole last week and state[d] her pain has improved since then” (see Tr. 918), suggesting the medications were switched earlier in July. In August 2021, Ms. Thornton went to her primary-care physician complaining of continuing stomach issues. (Tr. 980). The progress note for that visit notes that the doctor “[a]dvised patient that she likely has IBS” (Tr. 981) but also

reported the “gastroenterologist advised that because the colonoscopy is negative, she does not have IBS.” (Tr. 980). Ms. Thornton is assessed with malnutrition (Tr. 361) so her body mass index5 was regularly monitored: November 21, 2016 17 (Tr. 486) March 31, 2017 18 (Tr. 514) April 24, 2017 17.04 (Tr. 828) May 2, 2017 16.8 (Tr. 831) March 4, 2018 17.97 (Tr. 840) June 3, 2019 21.06 (Tr. 360) January 29, 2020 20.7 (Tr. 846) October 2, 2020 19 (Tr. 703)

3 Omepazole is used to treat gastroesophageal reflux disease (GERD) by reducing the amount of stomach acid that can flow into the esophagus. See Omepazole, MedlinePlus, http://medlineplus.gov/druginfo/meds/a693050.html (last accessed Nov. 25, 2025). 4 Pantropazole is used to treat GERD by reducing the amount of stomach acid. See Pantroprazole, MedlinePlus, http://medlineplus.gov/druginfo/meds/a601246.html (last accessed Nov. 25, 2025). 5 Body mass index (BMI) is defined as “the ratio of your weight to the square of your height” and is calculated through one of three formulae depending on the units used to measure weight and height. See Listing 5.00(F), 20 C.F.R. Pt. 404, Subpt. P, App. 1, § 5.00(F). October 22, 2020 18.75 (Tr. 834) December 31, 2020 18 (Tr. 759) February 19, 2021 19.47 (Tr. 856) March 17, 2021 17.97 (Tr. 859) June 29, 2021 16.8 (Tr. 864) August 13, 2021 17.19 (Tr. 867) October 29, 2021 17.97 (Tr. 982) November 17, 2021 18.09 (Tr. 984) August 16, 2022 17.58 (Tr. 1007)

III.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
Jessica Thornton v. Commissioner of Social Security, Counsel Stack Legal Research, https://law.counselstack.com/opinion/jessica-thornton-v-commissioner-of-social-security-ohnd-2025.